chrisvoncsefalvay/vaers-outcomes huggingface dataset:
her arm still hurts; was a little tired; had a little chill; This is a spontaneous report from a contactable consumer reported for herself. An 82-years-old female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Left on 13Apr2021 10:30 am (Batch/Lot Number: ER8727) as SINGLE DOSE for covid-19 immunization, at the age of vaccination of 82 years old.  Medical history included  she was fine and had the covid too and did not know she had it and was tested for antibodies and gave covid to her husband; stated she had antibody testing but did not remember when the testing was but was maybe in Jan2021; stated she had covid in Nov2020 and one day she did not feel good and had a sore throat thinking she was getting a cold with a scratchy throat and never thought it was covid. Historical vaccine included 1st dose of the Pfizer Vaccine was administered in her left arm on 23Mar2021 with lot EN6208. The patient's concomitant medications were not reported.  None Prior Vaccinations (within 4 weeks). The patient experienced was a little tired (non-serious) on 13Apr2021 with outcome of recovered on 13Apr2021, had a little chill (non-serious) on 13Apr2021 with outcome of recovered on 13Apr2021, her arm still hurts (non-serious) on an unspecified date with outcome of recovering.  The patient underwent lab tests which included sars-cov-2 antibody test: unknown result on Jan2021.  Therapeutic measures were taken as a result of her arm still hurts. Caller stated she got so nervous when he became sick regarding her husband. Caller stated she was a little tired and had a little chill about 1pm in the afternoon; states she had the Pfizer Vaccine 2nd dose at 10:30am on 13Apr2021; stated the chill and tiredness was not ongoing and she was fine and these reported events were resolved as of yesterday afternoon. Stated she put ice on her arm after the Pfizer Vaccine 2nd dose and her arm still hurts and hurt a little bit yesterday. Stated she did not require treatment for the reported events.  Caller stated the tiredness and chills lasted about an hour and she felt them when she was asleep and was tired all of a sudden. AEs not require a visit to ER or MD office.   No follow-up attempts are needed. No further information is expected.
Pt came in office on 4/25/13 and returned on 5/3/13 with c/o swelling and redness at injection site. Pt had fading purplish pink erythema about 4 cm.
The pt experienced a large red swollen area on the arm, the area is hot. Took Motrin and used cold compresses to treat.
the syringe did not work well; Patient received less of the dose/ not had launch the hole dose/received less than half of the dose and not repeating dose if patient received more that half of the; This spontaneous case was reported by a pharmacist and describes the occurrence of INCORRECT DOSE ADMINISTERED (Patient received less of the dose/ not had launch the hole dose/received less than half of the dose and not repeating dose if patient received more that half of the) and DEVICE CONNECTION ISSUE (the syringe did not work well) in a 121-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 12-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-May-2021, the patient experienced INCORRECT DOSE ADMINISTERED (Patient received less of the dose/ not had launch the hole dose/received less than half of the dose and not repeating dose if patient received more that half of the). On an unknown date, the patient experienced DEVICE CONNECTION ISSUE (the syringe did not work well). At the time of the report, INCORRECT DOSE ADMINISTERED (Patient received less of the dose/ not had launch the hole dose/received less than half of the dose and not repeating dose if patient received more that half of the) and DEVICE CONNECTION ISSUE (the syringe did not work well) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Relevant concomitant medications was reported.  Pharmacist called in to report that a patient received the second dose of the Moderna vaccine on 12 May 2021, and the syringe did not work well, and patient may not had launch the hole dose. Pharmacist said he knew the recommendation of repeating dose in opposite arm if patient received less than half of the dose and not repeating dose if patient received more that half of the dose, but wanted to know if there was any problem repeating the dose 5 or more days after the administration error. The patient is not experiencing any symptoms, but complained about receiving less dose.
Information has been received from the patient's sister referring to a 67 years old female patient with hypothyroidism. The patient had drug reactions/allergies: ACHROMYCIN. In the third week of March 2016, the patient was vaccinated with a dose of ZOSTAVAX (1 shot) subcutaneously. Concomitant medication included Thyroid medication. On 11-APR-2016 (reported as 3 weeks ago) (also reported as subsequently), the patient broken out with what appears to be a case of Chickenpox. The outbreak started slowly, about two weeks after the vaccine was administered. She had originally had a few pustules, which she attributed to being common acne pimples. Within a few days, the pustules appeared more and more, eventually covering her face. She hadn't had any new blotches in 4 days, and they were drying up, but not necessarily draining. The blisters were only localized on the face. She had visited her doctor on the 25-APR-2016, and he had prescribed unspecified antivirals for the infection. No lab diagnostics studies were performed. The outcome of the event was reported as recovering/resolving. Causality was not reported. Additional information has been requested.
Feeling body aches; Feeling fatigue; This spontaneous case was reported by a physician assistant (subsequently medically confirmed) and describes the occurrence of PAIN (Feeling body aches) and FATIGUE (Feeling fatigue) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse effect (No medical history provided).    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Jan-2021, the patient experienced PAIN (Feeling body aches) and FATIGUE (Feeling fatigue). At the time of the report, PAIN (Feeling body aches) and FATIGUE (Feeling fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Treatment medication included Paracetamol.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the reported events, a causal relationship cannot be excluded.
Info has been received from a physician concerning a 12 year old male who in 1998 was vaccinated with a dose of varicella virus vaccine live. In February 2005, the pt developed a full blown case of chicken pox. Subsequently, the pt recovered. Unspecified medical attention was sought. No product quality complaint was involved. Additional info has been requested.
Pain; Swelling; Pain down to elbow; Fever of 99 F; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain), SWELLING (Swelling), ARTHRALGIA (Pain down to elbow) and PYREXIA (Fever of 99 F) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No reported medical history.  Concomitant products included ACETAMINOPHEN for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced PAIN (Pain), SWELLING (Swelling), ARTHRALGIA (Pain down to elbow) and PYREXIA (Fever of 99 F). At the time of the report, PAIN (Pain), SWELLING (Swelling), ARTHRALGIA (Pain down to elbow) and PYREXIA (Fever of 99 F) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided by the reporter.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 03-Jun-2021: Events onset date has been updated and denied consent to contact
with in 10 min of administration pt complained of light headedness and sweating / clammy.  She was sitting and put her head down between her knees.  An attempt to monitor blood pressure read 45/20. She then fainted for just a few seconds.  911 was called.  An Epi-pen was andministered and patient was helped to a lying postion on the floor where she remained until EMT's arrived.  Upon their evaluation pt was transported to the hospital for further monitoring.
Severe muscle pain all over body. Headache. Mild fever. Severe chills. Lasting at least 17 hours (still ongoing) and preventing work and daily activities. So far rest and tylenol alternating with advil to help control pain/fever.
c/o swelling of arm, axilla, shoulder (LA) 24 hours after injection no c/o fever or pain.
COVID (disease); she could not raise or move her left arm (she could not pick up a cup of coffee) / she still has problems using her left arm but is better than it was; hearing loss in her left ear; swollen left hand/ swollen left arm; throat redness; throat burning; throat swelling; hair loss; shingles; This spontaneous report was received from a consumer referring to herself, a 74-year-old female patient with penicillin allergy and on hospice care. No information regarding the patient's medical history or concomitant medications was provided.  On an unknown date, reported as 12 years ago, when "the patient turned 60", she was first vaccinated with a dose of zoster vaccine live (ZOSTAVAX) (dose, frequency, route of administration, lot# and expiration date were not reported) for prophylaxis. On an unknown date in 2020, reported as last year, the patient received a new double shot vaccine (not otherwise specified) (dose, frequency, route of administration, lot# and expiration date were not reported).  On 19-OCT-2021, she was vaccinated with a dose of varicella zoster vaccine rge (cho) (SHINGRIX), solution for injection, probably on left arm (dose, frequency, route of administration were not reported), lot # 7742Z, expiration date: 25-MAR-2023, and with a dose of influenza vaccine (manufacturer unknown), reported as flu vaccine, in right arm (dose, frequency, route of administration, lot# and expiration date were not reported), both for prophylaxis.  On an unknown date in October 2021, the patient experienced multiple reactions: hearing loss in her left ear, swollen left hand and swollen left arm, throat redness, throat burning, throat swelling and hair loss. She stated that she could not raise or move her left arm (she stated that she could not pick up a cup of coffee) starting on 20-OCT-2021. She admitted that she still had problems using her left arm but it seemed better than it was on 20-OCT-2021 and 21-OCT-2021. On an unknown date, the patient experienced Coronavirus disease 2019 (COVID-19) disease. On an unknown date, reported as now, she had shingles and "she would not say, it was a mild case", additionally, shingles (disease) was also reported as the patient's medical history (clarification regarding discrepancies pending).  The outcome of hearing loss in her left ear, swollen left hand and swollen left arm, COVID-19 disease, hair loss, throat redness, throat burning, throat swelling and shingles was unknown. The outcome of peripheral swelling was reported as recovering/resolving.  The causality assessment between the events and zoster vaccine live (ZOSTAVAX) and influenza vaccine (manufacturer unknown) was not provided. The relatedness between zoster vaccine rge (cho) (SHINGRIX) and hearing loss in her left ear, swollen left hand swollen left arm, could not raise or move her left arm,  throat redness, throat burning, throat swelling, and hair loss was related. The causality assessment between zoster vaccine rge (cho) (SHINGRIX) and COVID-19 disease and shingles was not reported.  Upon internal review, the event of hearing loss in her left ear was considered to be medically significant.
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose 12/30/20202 2nd dose: 01/28/21,Lot#  Diagnosed covid positive:08/09/21 Symptom onset:08/09/21 Exposure:Community Symptoms:Nasal congestion , postnasal drip, sneezing
Experienced 103° F fever with shaking chills, lightheadedness and nausea. 400mg Ibuprofen was self administered and resolved the issues within 30-45 minutes. Fever started at 5:15am and broke (started sweating) around 6am.
Patient developed a left axilla/breast swelling and inflammation that developed 8-10 days after the shot and initially steadily got worse. She has had persistent pain since the vaccine and intermittent swelling and inflammation over a month later. Now, the lateral side of left breast hurts over to the nipple.
eye is itchy, it's bloodshot and tearing in one eye; eye is itchy, it's bloodshot and tearing in one eye; eye is itchy, it's bloodshot and tearing in one eye; This is a spontaneous report from a non-contactable consumer (wife). A male patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration, on 06Feb2021 at a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced eye is itchy, it's bloodshot and tearing in one eye on 09Feb2021. The clinical outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
consulted MD on 31JAN as lt upper arm swollen, size of teacup as reported per mom & red;ice applied for duration of swelling;APAP given for discomfort;
Pt received Varicella vaccine subcutaneous in right lower arm on 8/14/18 -swelling and redness from shoulder to elbow with pain.
Over the last 36 hours: fever of 103.5, extreme chills, body aches, nausea, and severe flu-like symptoms.
Nausea, vomiting and severe abdominal pain began 1/27/22. Since then he experiences severe migraine headaches lightheadedness, chills, acute abdominal pain and vomiting. He had full lab workups, diagnostic testing's, visits.  Patient was out of work for 16 weeks and gradually went back to work continually vomiting 4-5 days out of the week along with the abdominal pain.  Multiple medications were administered on trials to see how it would benefit him.
This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). A 95-year-old female patient received BNT162b2 (BNT162B2), on 03Aug2021 as dose 1, single (Batch/Lot number: unknown) at the age of 94 years, in arm for covid-19 immunisation. The patient's relevant medical history included: "thyroid disorder" (unspecified if ongoing); "eye drops" (unspecified if ongoing). Concomitant medication(s) included: LEVOTHYROXINE taken for thyroid disorder; DORZOLAMIDE + TIMOLOL taken for eye drop instillation; LATANOPROST. The following information was reported: DYSSTASIA (non-serious), outcome "unknown", described as "Her mother couldn't stand that day after her first Pfizer COVID-19 Vaccine"; GAIT INABILITY (non-serious), outcome "unknown", described as "not able to walk". Relevant laboratory tests and procedures are available in the appropriate section. Additional information: No additional vaccines was administered on same date of the Pfizer Suspect. The patient had no prior vaccinations within four weeks prior to the first administration date of the suspect vaccine. The patient had home COVID test and was negative and an official COVID test was done on 01Aug2022 with results on 03Aug2022 prior to her chest x-ray. The patient was not a big person for shots and her daughter was very worried her mother would pass away and has not had all her vaccines (as reported). The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Late in the evening I noticed a sore throat.  The next day Extreme fatigue, anorexia, and sore throat got worse.  Slept for 22 hours. Tested with an At Home COVID-19 Test, positive.  Televisit with doctor who proscribed Paxlovid.  1/26 slept 15 hours, eating a little and sore throat.  1/27 sore throat, eating better and feeling better.  Severe metallic taste from Paxlovid.  By the 5th day, symptoms diminished.  Antigen test took 2 weeks to show negative.
Felt bloated; Body felt very heavy; Head felt very heavy; Heaviness in her legs; Very high fever during the day and at night for two consecutive days; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISTENSION (Felt bloated), DISCOMFORT (Body felt heavy), HEAD DISCOMFORT (felt heavy), LIMB DISCOMFORT (Heaviness in her legs) and PYREXIA (Very high fever for two consecutive days) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination.     No medical history was provided by the reporter. .  Concomitant products included BISOPROLOL FUMARATE for an unknown indication.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2021, the patient experienced ABDOMINAL DISTENSION (Felt bloated), DISCOMFORT (Body felt heavy), HEAD DISCOMFORT (Head felt heavy), LIMB DISCOMFORT (Heaviness in her legs) and PYREXIA (Very high fever during the day for two consecutive days). The patient was treated with ACETAMINOPHEN for Fever, at a dose of 650 mg. On 18-Apr-2021, PYREXIA (Very high fever for two consecutive days) had resolved. At the time of the report, ABDOMINAL DISTENSION (Felt bloated), DISCOMFORT (Body felt heavy), HEAD DISCOMFORT (Head felt heavy) and LIMB DISCOMFORT (Heaviness in her legs) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Client received his 1st COVID19 Pfizer vaccine on 07.18.21 and came in on 08.08.21 to receive his 2nd COVID19 Pfizer dose with RN 1.  He disclosed to RN 1 that he believed he may have had an adverse reaction to his 1st dose and RN 1 requested Lead RN, come and speak to the client.  The client communicated that 15-20 minutes after receiving his 1st dose of the vaccine, he experienced chest tightness which lasted 2-3 hours.  While he was at hospital when the discomfort started, the client did not alert an EMT of his condition.  Rather, he chose to leave and go home.  The client stated the level of discomfort experienced was around a 3 on a scale of 0-10.  He also stated he has experienced the same discomfort on and off every other day for approximately 30-60 minutes since he received his 1st dose.  The client did not receive medical treatment or take any medication for his discomfort.  The only other side effect he has experienced is fatigue.  The client stated he ate and drank plenty prior to receiving his 1st vaccine shot and prior to coming in today to receive his 2nd dose.  The client has no known allergies and takes no medications.  However, he does smoke marijuana and uses various CBD products to relax.  He did disclose that he struggles with anxiety and depression.  He stated he believes that his chest discomfort could have been due to these struggles, but was unsure.  Lead RN escalated the client?s concerns to Clinical Care Coordinator.  She indicated it was safe to administer a 2nd COVID19 Pfizer vaccine to the client with a 30-minute wait.  Lead RN spoke to the client and explained potential side effects of the vaccine.  Lead RN instructed client to go to urgent care if he started to experience extreme side effects and/or dizziness and to call 911 if he started to experience any difficulties breathing, shortness of breath, or chest pain.  Client stated he understood.  RN 1 proceeded with administering the client?s 2nd dose of the COVID19 Pfizer vaccine.
At approximately 1102 (15 min after vaccine admin) pt c/o generalized itching without rash, headache and fatigue. Denied any difficulty breathing or swallowing. BP 163/99, HR 65, O2 95%, RR 16 (pt notes baseline hypertension). Attending provider, Dr. (Name), notified of pt's symptoms, bedside assessment performed, 50mg Benadryl IM ordered and given at 1110. At approx. 1120 pt c/o intermittent chest pain, describes as stabbing, and mild difficulty swallowing. BP 186/100, O2 96%, HR 74, RR 16. Provider updated, continued to monitor. At approx. 1125 pt notes increased itching, BP 161/103, HR 59, 02 97%, HR 18. Pt assisted to supine position with HOB elevated. Continued to deny difficulty breathing. Approx 30 min admin of Benadryl pt noted initial improvement of itching, BP 173/93, HR 58, O2 96%, RR 18. After approx. 1 hr after vaccine admin pts states symptoms mostly resolved, bedside assessment performed by Dr. (Name), pt cleared for d/c home.
Sore arm; Vertigo / side effect caller was having were related to vertigo; Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO, DIZZINESS, and PAIN IN EXTREMITY in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, the patient experienced VERTIGO and DIZZINESS. On an unknown date, the patient experienced PAIN IN EXTREMITY. At the time of the report, VERTIGO, DIZZINESS, and PAIN IN EXTREMITY outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was provided as MECLOZINE HYDROCHLORIDE.   Most recent FOLLOW-UP information incorporated above includes: On 14-May-2021: Significant follow up received. The side effects caller was having were related to vertigo. There is no connection of side effects with vaccine
This spontaneous report has been received from a nurse practitioner referring to a 65 year old female patient. The patient's medical history and concurrent conditions were not provided. On 03-FEB-2016 the patient was vaccinated with an expired dose of PNEUMOVAX 23 (strength, dose, and frequency were not provided), (lot # K005402 expired date 07-NOV-2015). Concomitant therapies were not provided. The nurse practitioner also reported that the dose of PNEUMOVAX 23 had been exposed to different temperatures outside of the recommended range, 35F for 12 hours and 33F for 12 hours prior to administration. The patient did not report an adverse experience. Product quality complaint was not involved. Additional information has been requested.
Passed out 10 mins after injection. Several small hives to neck that passed quickly, c/o numbness to tongue & hands. Sent to Emergency Room.